Aspen aerogels inc (ASPN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Revenue:
Total revenue

28,419

46,505

35,425

29,533

27,912

35,679

23,937

21,671

23,074

-

27,198

25,069

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product

-

-

-

-

-

-

-

-

-

-

-

-

22,326

-

28,877

27,123

32,286

36,640

30,926

29,755

23,211

27,284

24,589

25,893

21,493

20,833

21,801

Research services

-

-

-

-

-

-

-

-

-

-

-

-

676

-

683

595

535

743

613

341

289

700

848

722

870

1,047

1,177

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

23,002

-

29,560

27,718

32,821

37,383

31,539

30,096

23,500

27,984

25,437

26,615

22,363

21,880

22,978

Cost of revenue:
Product

-

-

-

-

-

-

-

-

-

-

-

-

20,470

-

22,790

20,723

25,992

27,189

26,017

24,814

18,845

22,360

19,926

22,850

18,541

17,769

18,876

Research services

-

-

-

-

-

-

-

-

-

-

-

-

311

-

368

342

302

341

350

173

141

387

439

340

476

531

571

Gross profit

5,980

11,310

7,742

3,514

3,718

5,586

1,529

2,744

2,810

7,808

4,948

3,694

2,221

3,729

6,402

6,653

6,527

9,853

5,172

5,109

4,514

5,237

5,072

3,425

3,346

3,580

3,531

Operating expenses:
Research and development

2,227

2,565

2,046

1,868

1,928

1,692

1,384

1,638

1,605

1,427

1,468

1,709

1,576

1,382

1,328

1,286

1,310

1,252

1,146

1,551

1,304

1,518

1,258

1,920

1,284

1,387

1,178

Sales and marketing

3,324

4,545

3,992

3,509

3,511

3,513

3,061

3,721

3,499

3,333

2,745

3,416

3,110

2,871

3,056

2,821

3,062

2,715

2,793

2,722

2,332

2,419

2,213

3,420

2,238

2,505

2,439

General and administrative

3,515

5,030

3,857

3,352

4,240

6,967

3,453

4,240

4,456

4,669

3,765

4,002

6,587

5,186

4,422

3,894

3,913

4,202

3,709

3,534

3,623

3,959

3,966

6,206

2,722

4,353

2,552

Total operating expenses

9,066

12,140

9,895

8,729

9,679

19,528

7,898

9,599

9,560

9,429

7,978

9,127

11,273

9,439

8,806

8,001

8,285

8,169

7,648

7,807

7,259

7,896

7,437

11,546

6,244

8,245

6,169

Loss from operations

-3,086

-830

-2,153

-5,215

-5,961

-13,942

-6,369

-6,855

-6,750

-1,621

-3,030

-5,433

-9,052

-5,710

-2,404

-1,348

-1,758

1,684

-2,476

-2,698

-2,745

-2,659

-2,365

-8,121

-2,898

-4,665

-2,638

Interest expense, net

-83

-126

-136

-103

-41

-166

-163

-103

-92

-62

-58

-39

-26

-32

-37

-39

-39

-46

-46

-45

-45

-56

-47

-34,027

-16,151

-

-

Postponed financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

656

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,038

-15,620

Loss on exchange of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-485

Costs associated with postponed public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

241

Total interest expense, net

-83

-126

-136

-103

-41

-166

-163

-103

-92

-62

-58

-39

-26

-32

-693

-39

-39

-46

-46

-45

-45

-56

-47

-34,027

-16,151

-8,038

-16,346

Net loss

-3,169

-956

-2,289

-5,318

-6,002

-14,108

-6,532

-6,958

-6,842

-1,683

-3,088

-5,472

-9,078

-5,742

-3,097

-1,387

-1,797

1,638

-2,522

-2,743

-2,790

-2,715

-2,412

-42,148

-19,049

-12,703

-18,984

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,412

-42,148

-19,049

-12,703

-18,984

Net loss per share:
Basic and diluted

-0.13

-0.04

-0.09

-0.22

-0.25

-0.60

-0.27

-0.29

-0.29

-0.08

-0.13

-0.23

-0.39

-0.25

-0.13

-0.06

-0.08

-

-

-

-

-

-

-

-

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

-0.12

-0.12

-

-0.10

-13.88

-6,066.56

-4,049.41

-6,051.64

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

-0.12

-0.12

-

-0.10

-13.88

-6,066.56

-4,049.41

-6,051.64

Weighted-average common shares outstanding:
Basic and diluted

25,194

24,176

24,171

24,118

23,930

23,836

23,808

23,743

23,567

23,491

23,442

23,369

23,257

23,216

23,168

23,111

23,063

22,895

23,060

22,999

22,992

23,361

22,997

3,035

3

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

3

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

3

Product [Member]
Total revenue

28,307

46,195

35,046

28,908

26,785

35,145

23,342

21,115

22,521

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

22,399

35,056

27,510

25,715

23,478

29,807

22,154

18,676

20,023

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research Services [Member]
Total revenue

112

310

379

625

1,127

534

595

556

553

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

40

139

173

304

716

286

254

251

241

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-